US Drug Lobby Group PhRMA Names Former House Leader Cantor as CEO
Cantor will take over as PhRMA faces pressure over drug pricing and regulation, with member companies investing more than $850 billion in new treatments.
- On Tuesday, the Pharmaceutical Research and Manufacturers of America named former United States House Majority Leader Eric Cantor as its next president and chief executive officer, effective November 9.
- Cantor, who served as House Majority Leader from 2011 to 2014, brings experience from his recent role as vice chairman and managing director at Moelis & Company after departing Congress.
- During his congressional tenure, Cantor helped pass the 21st Century Cures Act, which provided significant funding for the National Institutes of Health and included Food and Drug Administration reforms designed to speed medicine approvals.
- He succeeds CEO Stephen Ubl, who led PhRMA since 2015 during a period when the pharmaceutical industry faced intense pressure from lawmakers and United States administrations over prescription drug pricing, market access, and regulation.
- Consumer watchdog Public Citizen criticized the appointment, calling Cantor an "experienced reverse Robin Hood," while PhRMA spent a record $38 million on lobbying to counter legislative pressure on drug prices.
11 Articles
11 Articles
'A Match Made in Hell': Former GOP House Leader to Head Big Pharma Lobby
In what advocates for lower drug prices called "a match made in hell," one of the pharmaceutical industry's most powerful lobbying groups is tapping a former Republican leader in the US House to lead its political operations.
US drug lobby group PhRMA names former House leader Cantor as CEO - Regional Media News
Sept 29 (Reuters) - The US pharmaceutical lobby group Pharmaceutical Research and Manufacturers of America said on Tuesday it had named former US House Majority Leader Eric Cantor as its next president and chief executive officer. Cantor, who served in the US House of Representatives [...]
Eric Cantor takes the helm of drug lobbying Giant Pharma - The Daily Bo Snerdley
Former Republican Virginia Rep. Eric Cantor has been tapped as the next president and CEO of the Pharmaceutical Research and Manufacturers of America, the organization announced Tuesday. The top lobbying group said in its news release that Cantor will assume the new role effective Nov. 9. Cantor represented Virginia’s 7th congressional district in the U.S. House of Representatives from 2000 to 2014, and served as House majority leader from 2011 …
Coverage Details
Bias Distribution
- 56% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
